Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  CVS Health Corp    CVS

Delayed Quote. Delayed  - 07/22 10:03:20 pm
96.55 USD   -0.41%
07/22 CVS HEALTH CORP : To Hold Second Quarter 2016 Conference Call
07/19 CVS HEALTH CORP : ex-dividend day
07/18 CVS HEALTH : Free Clinic receives $10,000 grant from CVS
News SummaryMost relevantAll newsSector news 

CVS Caremark Corporation : U.S. asks CVS about its prescription discount plan

share with twitter share with LinkedIn share with facebook
share via e-mail
02/17/2012 | 10:28pm CEST

CVS Caremark Corp said it received requests for information about a prescription drug discount program it runs for uninsured or under-insured individuals from both the U.S. government and the Texas Attorney General.

In January, CVS received a subpoena from the U.S. Office of Inspector General requesting information about the company's Health Savings Pass program, CVS said in its 10k filing on Friday.

The company, which runs the CVS pharmacy chain and the CVS Caremark pharmacy benefits management service, said the request was connected to an investigation of possible false or otherwise improper claims for payment involving Health & Human Services programs.

In February, CVS received a civil investigative demand from Texas' Office of the Attorney General. That office requested a copy of information from the OIG subpoena and other information related to prescription drug claims submitted by CVS pharmacies to Texas Medicaid for reimbursement, the company said.

CVS said it would respond to the requests for information and cooperate with both investigations.

CVS markets its Health Savings Pass, which has a $15 annual fee, to people who do not have prescription drug coverage and to those who have limited coverage.

The Health Savings Pass lets patients fill 90-day prescriptions for 400 generic drugs for $11.99. Participants also get discounts such as 10 percent off visits at the CVS in-store health clinic, MinuteClinic and 10 percent off an annual flu shot.

The announcement comes about a month after CVS agreed to pay $5 million to settle charges of inaccurate pricing of some drugs for the elderly and disabled, ending a wide-ranging, multi-year probe into its business practices.

Shares of CVS closed down 28 cents at $44.27, after reaching a new high of $45 earlier in the day.

(Reporting by Jessica Wohl in Chicago; Editing by Richard Chang)

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on CVS HEALTH CORP
07/22 CVS HEALTH CORPORATION : To Hold Second Quarter 2016 Conference Call
07/21 CVS HEALTH : Lipinski Announces Installation of Drop Box for Unwanted Prescripti..
07/19 CVS HEALTH CORP : ex-dividend day
07/18 CVS HEALTH : Free Clinic receives $10,000 grant from CVS
07/15 CVS HEALTH : Specialty Pharmacy Facility Opens in Orlando
07/15 CVS HEALTH : Research Institute Study Shows that Medication Reconciliation Progr..
07/14 CVS HEALTH : Foundation and American Academy of Pediatrics Announce New Initiati..
07/14 CVS HEALTH : FENWAY PARK Burlington veteran attends baseball camp
07/14 CVS HEALTH : Honor Local veterans honored at Fenway Park
07/14 CVS HEALTH : Play ball!
More news
Sector news : Drug Retailers - NEC
07/21 MCKESSON : Theranos hires executives in regulatory, compliance push
07/21DJTheranos Hires Compliance, Regulatory Executives
07/21DJSINOPHARM : to Inject Certain Assets Into China National Medicines for CNY5.37 B..
07/18DJStarbucks Widens Workers' Health-Insurance Options
07/13DJWALGREENS BOOTS ALLIANCE : Boosts Its Quarterly Dividend 4.2%
More sector news : Drug Retailers - NEC
News from SeekingAlpha
07/22 6 MONTH PORTFOLIO UPDATE : Good News, Double-Digit Increase In Both Income And V..
07/22 CVS HEALTH : Stock Valuations Are Compelling
07/21 CONSUMER STAPLES : Finding Value In An Expensive Sector
07/21 The Happy Gilmore Market And My Search For Attractive Multiples At Today's Pr..
07/21 Risk-Reward Of The Market - Cramer's Mad Money (7/20/16)
Financials ($)
Sales 2016 181 303 M
EBIT 2016 10 754 M
Net income 2016 5 791 M
Debt 2016 25 246 M
Yield 2016 1,69%
P/E ratio 2016 17,77
P/E ratio 2017 15,50
EV / Sales 2016 0,71x
EV / Sales 2017 0,65x
Capitalization 103 697 M
More Financials
Duration : Period :
CVS Health Corp Technical Analysis Chart | CVS | US1266501006 | 4-Traders
Full-screen chart
Technical analysis trends CVS HEALTH CORP
Short TermMid-TermLong Term
Technical analysis
Income Statement Evolution
More Financials
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 112 $
Spread / Average Target 16%
Consensus details
EPS Revisions
More Estimates Revisions
Larry J. Merlo President, CEO & Non-Independent Director
David Wyatt Dorman Non-Executive Chairman
David M. Denton Chief Financial Officer & Executive Vice President
Troyen A. Brennan Chief Medical Officer & Executive Vice President
Stephen J. Gold Chief Information Officer & Executive Vice Preside
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CVS HEALTH CORP-1.25%103 697
More Results